• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Etched Nanopillars Kill Bacteria, Fungi on Titanium Implants

      Etched Nanopillars Kill Bacteria, Fungi on Titanium Implants

      Cells Release Insulin in Response to Music

      Cells Release Insulin in Response to Music

      Microneedle Skin Patch Measures Cancer Biomarkers

      Microneedle Skin Patch Measures Cancer Biomarkers

      Enzyme Treatment Strips Mucins from Cancer Cells

      Enzyme Treatment Strips Mucins from Cancer Cells

    • Radiology
      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Wearable Ultrasound for Deep Tissue Monitoring

      Wearable Ultrasound for Deep Tissue Monitoring

    • Cardiology
      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      3D Printed Heart Muscle Beats

      3D Printed Heart Muscle Beats

      Wireless Patch Monitors, Paces Heart and then Biodegrades

      Wireless Patch Monitors, Paces Heart and then Biodegrades

      Photonic Radar Monitors Breathing from a Distance

      Photonic Radar Monitors Breathing from a Distance

    • Surgery
      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Highly Precise Pressure Sensor for Laparoscopic or Robotic Surgical Tools

      Highly Precise Pressure Sensor for Laparoscopic or Robotic Surgical Tools

      Magnetic Tentacle Robots for Minimally Invasive Procedures

      Magnetic Tentacle Robots for Minimally Invasive Procedures

      Artificial Muscle Changes Stiffness with Voltage

      Artificial Muscle Changes Stiffness with Voltage

    • Nanomedicine
      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

    • Military Medicine
      Wearable Can Take Multiple Sweat Samples

      Wearable Can Take Multiple Sweat Samples

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

    • Rehab
      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Brain Computer Interface Decodes Speech and Facial Expressions

      Brain Computer Interface Decodes Speech and Facial Expressions

      Semi-Automated Manufacture of E-Skin Sensors

      Semi-Automated Manufacture of E-Skin Sensors

      Above Elbow Amputee Controls Individual Bionic Fingers

      Above Elbow Amputee Controls Individual Bionic Fingers

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Chronic Liver Diseases Therapeutics Market Is Expected To Reach US$ 24.9 Billion With Growing CAGR of 9.7% By 2027 | Astellas Pharma Inc., Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline Plc

January 28th, 2022 Coherent Market Insights Releases

 

Global Chronic Liver Diseases Therapeutics Market

In 2015, according to the National Survey on Drug Use and Health (NSDUH) data, around 88,000 people (around 62,000 men and 26,000 women) died due to alcohol-related causes annually, which makes alcohol consumption the fourth leading preventable cause of death in the U.S. Such rise in prevalence of liver disease is driving growth of the chronic liver diseases therapeutics market.

Similarly, the high number of patients with chronic liver disease such as cirrhosis is significantly contributing to the growth of the global chronic liver disease therapeutic market. For instance, in 2016, around 4.5 million adults were diagnosed with cirrhosis liver disease, out of which, 12.8 deaths occurred per 100,000 people. This is expected to drive growth of the global chronic liver disease therapeutics market.

๐“๐จ ๐†๐ž๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐‹๐š๐ญ๐ž๐ฌ๐ญ ๐‚๐จ๐ฏ๐ข๐๐Ÿ๐Ÿ— ๐ˆ๐ฆ๐ฉ๐š๐œ๐ญ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ @ https://www.coherentmarketinsights.com/insight/request-sample/4047

Global Chronic Liver Diseases Therapeutics Market – Impact of Coronavirus (Covid-19) Pandemic

The spread of coronavirus has negatively impacted the global chronic liver disease therapeutics market. The outbreak of this virus has hindered the growth of the global market. The U.S has the highest number of corona patients which is expected to impact the countryโ€™s economic condition. The U.S is high potential market for the pharmaceuticals industry, and the economic slowdown of the U.S economy is likely to impact the market for pharmaceutical drugs. Similarly, markets in India, Brazil, Russia and other economies are also suffering due to Covid-19 attack that is expected to impact on lowering the pharmaceutical growth.ย  Furthermore, due to COVID-19 pandemic, hospitals are closed in containment zones, that has slowed the hospital visits and stabilized the demand for therapeutic drugs of chronic liver diseases.

The global chronic liver diseases therapeutics market is estimated to be valued atย US$ 12.8 Bn in 2020ย and is expected to exhibit aย CAGR of 9.7%ย during the forecast periodย (2020-2027).

Global Chronic Liver Diseases Therapeutics Market – Restraints

Side effects and risks associated with consumption of such drugs are projected to hinder growth of the global liver disease therapeutics market. The side effects such as nausea, headache, fever loss of appetite, and drug-induced liver disease are usually occur due to consumption of liver disease drug. Moreover, availability of alternate treatment procedures such as organ transplantation and liver resection are also projected to restrict growth of the market.

Global Chronic Liver Diseases Therapeuticsย Market: Opportunities

Growing research and development of immunotoxins is projected to provide lucrative growth opportunities to players operating in the global chronic liver disease therapeutics market. For instance, GPC3 is a cell surface heparan sulfate proteoglycan that is overexpressed in hepatocellular carcinoma. Anti-GPC3 immunotoxins can be effective in the treatment of human hepatocellular carcinoma.

Moreover, clinical trials of new therapies are again projected to support market growth. For instance, in March 2018, the U.S. FDA granted Orphan Drug Designation for Protagonist Therapeutics, Inc.โ€™s PTG-300; a subcutaneous injectable in clinical development stage for the potential treatment of beta-thalassemia and liver fibrosis.

๐๐ฎ๐ฒ ๐๐จ๐ฐ ๐š๐ง๐ ๐†๐ž๐ญ ๐…๐ฅ๐š๐ญ ๐Ÿ‘๐ŸŽ% ๐ƒ๐ข๐ฌ๐œ๐จ๐ฎ๐ง๐ญ

๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐“๐ก๐ข๐ฌ ๐๐ซ๐ž๐ฆ๐ข๐ฎ๐ฆ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐“๐จ ๐€๐œ๐œ๐ž๐ฌ๐ฌ ๐…๐ฎ๐ฅ๐ฅ ๐ˆ๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง @ https://www.coherentmarketinsights.com/insight/buy-now/4047

Global Chronic Liver Diseases Therapeutics Market โ€“ Regional Analysis

On the basis of region, the global chronic liver disease therapeutics market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

The market in North America is expected to witness significant growth owing to presence of major players in the region. Players are focused on partnership strategies to expand their product portfolio. For instance, in April 2020, Alnylam Pharmaceuticals, Inc. collaborated with Dicerna Pharmaceuticals, Inc. for development and commercialization of investigational RNAi therapeutics for the treatment of alpha-1 antitrypsin deficiency-associated liver disease.

Asia Pacific is projected to experience significant growth over the forecast period owing to high disease prevalence in the region. For instance, according to the NCBI (National Center for Biotechnology Information), Asia Pacific accounted for 62.6% of global deaths due to liver disease in 2015.

Europe is also projected to experience growth in the global chronic liver disease therapeutics market due to increased prevelence of liver diseased population in European countries. For instance, according to data published by the UK Research Alcohol Association in 2017, around 7,700 people die from alcohol-related liver disease each year in the U.K.

Global Chronic Liver Diseases Therapeutics Market – Competitive Landscape

Key players operating in the global chronic liver disease therapeutics market are Astellas Pharma Inc., Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline Plc, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi S.A, Pfizer Inc., Takeda Pharmaceutical, Valeant Pharmaceuticals, Watson Pharmaceuticals, Inc., Theratechnologies Inc., Alnylam Pharmaceuticals, Inc., Protagonist Therapeutics, Inc., Dicerna Pharmaceuticals, Inc., Endo International, Provectus Biopharmaceuticals Inc., and MAX BioPharma, Inc.

๐“๐จ ๐†๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐๐ƒ๐… ๐๐ซ๐จ๐œ๐ก๐ฎ๐ซ๐ž ๐‡๐ž๐ซ๐ž @ https://www.coherentmarketinsights.com/insight/request-pdf/4047

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Therapy Type
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Market Trends
    • Key Developments
    • Impact Analysis
    • Regulatory Scenario
    • Reimbursement Scenario
    • New Drug Launches/Approvals
    • Mergers & Acquisitions
    • PEST Analysis
  4. Global Chronic Liver Diseases Therapeutics Market, by COVID-19 impact analysis
    • Pre COVID Impact
    • Post COVID Impact
    • Government Initiative
  5. Global Chronic Liver Diseases Therapeutics Market, By Therapy Type, 2016 โ€“ 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 โ€“ 2027
      • Segment Trends
    • Anti-Rejection Drugs/ Immunosuppressants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 โ€“ 2027, (US$ Million)
    • Chemotherapy Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 โ€“ 2027, (US$ Million)
    • Targeted therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 โ€“ 2027, (US$ Million)
    • Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 โ€“ 2027, (US$ Million)
    • Anti-Viral Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 โ€“ 2027, (US$ Million)
    • Immunoglobulins
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 โ€“ 2027, (US$ Million)
    • Corticosteroids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 โ€“ 2027, (US$ Million)
  6. Global Chronic Liver Diseases Therapeutics Market, By Distribution Channel, 2016 โ€“ 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 โ€“ 2027
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 โ€“ 2027, (US$ Million)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 โ€“ 2027, (US$ Million)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 โ€“ 2027, (US$ Million)

View Press Release: https://www.coherentmarketinsights.com/press-release/chronic-liver-diseases-therapeutics-market-3308

About US:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Sign up and submit a press release

Sponsored

Viral Vector Manufacturing in Gene Therapy and Vaccine Development

Health and Clean Air: Why Indoor Ventilation Matters

Health and Clean Air: Why Indoor Ventilation Matters

New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options

MedTech Outlook 2023 for Latin America Released

MedTech Outlook 2023 for Latin America Released

Packaging Compliance Labs (PCL) Celebrates Site Expansion in Grand Rapids, MI

interviews & reviews
UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

Visually Guided Uterine Biopsies in Physicianโ€™s Office: Interview with Allison London Brown, CEO of LUMINELLE

Visually Guided Uterine Biopsies in Physicianโ€™s Office: Interview with Allison London Brown, CEO of LUMINELLE

AI-Powered Pain Relief: Interview with Claire Smith, VP at Nevro

AI-Powered Pain Relief: Interview with Claire Smith, VP at Nevro

MISHA Knee Shock Absorber: Interview with Anton Clifford, CEO of Moximed

MISHA Knee Shock Absorber: Interview with Anton Clifford, CEO of Moximed

Shelf-Stable Breast Milk Powder: Interview with Dr. Vansh Langer, CEO at BBy

Shelf-Stable Breast Milk Powder: Interview with Dr. Vansh Langer, CEO at BBy

"We Are Electric" by Sally Adee: Medgadget Interviews the Author

"We Are Electric" by Sally Adee: Medgadget Interviews the Author

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
ยฉ Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email